Elevai Labs Receivables

Elevai Labs (ELAB) currently reports a receivables of $600K as of June 2026. That compares with $200K in the prior-year period — up 195.4% year over year. Use the charts on this page to explore Elevai Labs's receivables history and peer comparisons.

Elevai Labs's receivables increased from $200K to $600K — a 195.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elevai Labs reported $600K in receivables as of June 2026. That compares with $200K in the prior-year period — up 195.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $600K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elevai Labs, and consider following ELAB for alerts when major investors trade the stock.

Elevai Labs is classified in the Consumer Discretionary sector. On receivables, it currently shows $600K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing ELAB with unrelated industries.